EN 简
Molecular Therapy Oncolytics
2022年04月19日
Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors
Yansha Sun, Yiwei Dong, Ruixin Sun, Yifan Liu, Yi Wang, Hong Luo, Bizhi Shi, Hua Jiang, Zonghai Li
CLINICAL CANCER RESEARCH
2020年10月01日
Coexpression of IL7 and CCL21 Increases Efficacy of CAR T cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
Hong Luo, Jingwen Su, Ruixin Sun, Yansha Sun, Yi Wang, Yiwei Dong, Bizhi Shi, Hua Jiang, Zonghai Li
Molecular Therapy
2020年09月26日
Olaparib Suppresses MDSC Recruitment via SDF1a/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR T cells on Breast Cancer in Mice
Ruixin Sun, Hong Luo, Jingwen Su, Shengmeng Di, Min Zhou, Bizhi Shi, Yansha Sun, Guoxiu Du, Honghong Zhang, Hua Jiang, Zonghai Li
CLINICAL CANCER RESEARCH
2020年08月01日
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
Donghua Shi, Yaoping Shi, Ahmed O. Kaseb, Xingxing Qi, Yuan Zhang, Jiachang Chi, Qing Lu, Huiping Gao, Hua Jiang, HuamaoWang, Daijing Yuan, HongMa, HongyangWang, Zonghai Li, Bo Zhai
PNAS
2020年01月21日
LRCH1 deficiency enhances LAT signalosome formation and CD8+ T cell responses against tumors and pathogens
Chang Liu, Xiaoyan Xu, Lei Han, Xiaopeng Wan, Lingming Zheng, Chunyang Li, Zhaohui Liao, Jun Xiao, Ruiyue Zhong, Xin Zheng, Qiong Wang, Zonghai Li, Hualan Chene, Bin Wei, Hongyan Wang
Frontiers in Oncology
2019年12月19日
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR T cells
Hong Luo, Xiuqi Wu, Ruixin Sun, Jingwen Su, Yi Wang, Yiwei Dong, Bizhi Shi , Yansha Sun, Hua Jiang, Zonghai Li
Signal Transduction and Targeted Therapy
2019年09月20日
Genetically engineered T cells for cancer immunotherapy
Dan Li, Xue Li, Wei-Lin Zhou, Yong Huang, Xiao Liang, Lin Jiang, Xiao Yang, Jie Sun, Zonghai Li, Wei-Dong Han, Wei Wang
The Journal of Immunology
2019年07月01日
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma
Ying Liu, Shengmeng Di, Bizhi Shi, Honghong Zhang, Yi Wang, Xiuqi Wu, Hong Luo, Huamao Wang, Zonghai Li, Hua Jiang
Molecular Therapy
2019年04月29日
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
Xiuqi Wu, Hong Luo, Bizhi Shi, Shengmeng Di, Ruixin Sun, Jingwen Su, Ying Liu, Hua Li, Hua Jiang, Zonghai Li
Frontiers in Oncology
2019年04月17日
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR T cells
Shengmeng Di , Min Zhou, Zeyan Pan, Ruixin Sun, Muhua Chen, Hua Jiang, Bizhi Shi , Hong Luo, Zonghai Li